Three Times a Week is a Loser

Docs are not buying this three times a week as a better Copaxone. Does anyone know any companies hiring?

 

Total troll. Buying it in my territory. We get one neg publication and the competition hits the board.

 

We will downsize once our numbers aren't met. We don't need two reps with generic coming out early.

 

Scary and true

 

I have heard one rep and bigger territories from my in-house source.

 

Any idea of when??

 

Copaxone sales are holding up for now partly because they’re doing well with the conversion process but also because they’ve been raising the price of the drug,” said Gilad Alper, a senior analyst at Petach Tikva-based Excellence Nessuah Brokerage Ltd. “Now it’s all about whether a generic comes in at the end of the month.”

 

Thought they weren't going to keep back filling positions as people leave? Seems like they keep hiring while we all wait to see if they keep the new hires or those of us who have worked here for years when the layoffs come.

 

They always keep those who have the smaller salary.

 

My boss is all up in my shit already! We are going to be slaughtered as soon as generic hits. And of course my 3x share is not high enough. I am on a slow walk down the plank.

 

Don't worry about getting laid off. They are definitely going to cut this sales team at least in half but they never keep the people you think. They look at territories and where reps are located to decide whom to keep. They worry about litigation so many of the best, longest tenured, highest ranked will go, as well as, the poor performers. There is nothing you can do to increase your chances of staying. Things will come down to how the new territories are drawn, nothing else.

 

They need to get their hands on Synthetic Biologics patent before the generics hit. A 505 (b)(2) filing could delay the generics for years.

 

http://www.fiercepharma.com/story/teva-starts-process-close-15-its-production-sites/2014-05-06

 

Or they could Rx oral estriol with generic GA. But one would think there would be significant concern of breast cancer using these 2 agents together and that long term safety studies would need to be executed prior to approval.

 

Estriol is completely safe, you might be thinking of estradiol. from NIH:

Estriol has some unique physiological effects, which differentiate it from estradiol, estrone, and CEE. Estriol would be expected to carry less risk for breast cancer, although no randomized controlled trials have been documented. Synthetic progestins have a variety of negative cardiovascular effects, which may be avoided with progesterone.

 

Maybe so, but even this says no randomized controlled trials have been documented. I hope you're correct. Don't you still get asked about the 2005 article about Copaxone regarding breast cancer? I do every time one of my major accounts has a patient diagnosed who's been on GA.